Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-2568
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Correction to: Characterization of Creatine Kinase Levels in Tofacitinib‑Treated Patients with Ulcerative Colitis: Results from Clinical Trials ; day:10 ; month:10 ; year:2020 ; pages:1-2
Digestive diseases and sciences ; (10.10.2020), 1-2
- Urheber
-
Panaccione, Remo
Isaacs, John D.
Chen, Lea Ann
Wang, Wenjin
Marren, Amy
Kwok, Kenneth
Wang, Lisy
Chan, Gary
Su, Chinyu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10620-020-06638-z
- URN
-
urn:nbn:de:101:1-2020112622384238445714
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Panaccione, Remo
- Isaacs, John D.
- Chen, Lea Ann
- Wang, Wenjin
- Marren, Amy
- Kwok, Kenneth
- Wang, Lisy
- Chan, Gary
- Su, Chinyu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Outcome measurement in clinical trials for ulcerative colitis: towards standardisation
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Outcome measurement in clinical trials for ulcerative colitis: towards standardisation
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis
Cost Effectiveness of Tofacitinib for the Treatment of Moderate to Severe Active Ulcerative Colitis in Colombia
Characterization of Creatine Kinase Levels in Tofacitinib-Treated Patients with Ulcerative Colitis: Results from Clinical Trials
Tofacitinib: An Option for Acute Severe Ulcerative Colitis?
Experience of Tofacitinib Use in Pregnancy in Patients with Ulcerative Colitis
Tofacitinib as Induction and Maintenance Therapy in Japanese Patients with Active Ulcerative Colitis
Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis
Experience with Tofacitinib in Patients with Ulcerative Colitis: Data from a United States Claims Database
Real world evidence on the effectiveness and safety of tofacitinib in ulcerative colitis in Lebanon
5 Jahre Tofacitinib bei Colitis ulcerosa
Outcome measurement in clinical trials for ulcerative colitis: towards standardisation
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomes
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitis